HIGH Stock Overview
Cantourage Group SE operates as a medical cannabis company in Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cantourage Group SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €8.25 |
| 52 Week High | €13.80 |
| 52 Week Low | €5.86 |
| Beta | 0 |
| 1 Month Change | 7.84% |
| 3 Month Change | 36.82% |
| 1 Year Change | -18.96% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.39% |
Recent News & Updates
Shareholder Returns
| HIGH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 8.6% | 2.3% | 0.5% |
| 1Y | -19.0% | -28.6% | 1.3% |
Return vs Industry: HIGH exceeded the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: HIGH underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| HIGH volatility | |
|---|---|
| HIGH Average Weekly Movement | 13.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HIGH's share price has been volatile over the past 3 months.
Volatility Over Time: HIGH's weekly volatility has increased from 8% to 14% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | n/a | www.cantourage.com |
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.
Cantourage Group SE Fundamentals Summary
| HIGH fundamental statistics | |
|---|---|
| Market cap | €102.88m |
| Earnings (TTM) | -€969.38k |
| Revenue (TTM) | €5.22m |
0.0x
P/S Ratio0.0x
P/E RatioIs HIGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIGH income statement (TTM) | |
|---|---|
| Revenue | €5.22m |
| Cost of Revenue | €3.38m |
| Gross Profit | €1.83m |
| Other Expenses | €2.80m |
| Earnings | -€969.38k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HIGH perform over the long term?
See historical performance and comparison